OTLK

NASDAQStock

Outlook Therapeutics, Inc.

$0.40-0.02 (-5.20%)

52-Week Range

$0.39

$2.97

Key Stats

Market Cap

16.4M

P/E Ratio

—

Dividend Yield

—

Beta

-0.08

Volume

1.5M

Avg Volume

936.4K

Performance

-4.54%

-80.60%

-59.90%

YTD

-36.21%

-73.18%

-97.92%

-99.06%

Price Chart

ETF Exposure

OTLK is held by 8 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
IWC	iShares Micro-Cap ETF	0.00%	73,599	$32K	$1.27B	0.60%
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	46	$27	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	1,656	$986	$12.17B	0.24%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	8	$4	$337.7M	0.32%
VTI	Vanguard Total Stock Market ETF	0.00%	942,805	$415K	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	4,958	$3K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	427	$254	$1.29B	0.17%
VXF	Vanguard Extended Market ETF	0.00%	313,926	$138K	$84.10B	0.05%

About OTLK ETF Exposure

Outlook Therapeutics, Inc. (OTLK) is held by 8 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 16.4M, OTLK is a widely held institutional stock. The stock currently trades at $0.40. Investors can gain exposure to OTLK through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold OTLK, sorted by portfolio weight.